$TLRY +14.37% | Massive Breakout on Reform Hopes
Tilray Brands ($TLRY) surged over 14% today as investors piled in following renewed optimism around U.S. federal marijuana reform. The potential reclassification of cannabis from Schedule I to Schedule III could ease crippling tax pressures and validate the medical use of cannabis — a long-awaited catalyst for the industry.
🔍 Technical Analysis:
- Breakout Confirmed: TLRY convincingly broke through key resistance at $0.5880, closing near $0.6751 with intraday highs of $0.7003.
- Volume Spike: Highest volume in months signals strong conviction behind the move.
- Indicators:
- RSI approaching overbought territory (~70), reflecting momentum strength.
- MACD shows strong bullish crossover and acceleration.
- Next Resistance Levels:
- $0.7214 (immediate)
- $1.14 and $1.27 longer term
- Support Zones: $0.5880 and $0.4971 below.
🗓️ What’s Next?
- 🚨 Q4 & FY25 Earnings Incoming: TLRY will report after market close on July 28, with a webcast at 4:30 PM ET. Expect volatility around this event.
- 🌍 Global Expansion Continues: TLRY also received Italy’s first medical cannabis flower distribution approval, expanding its European footprint.
TLRY is still down ~53% YTD, but today’s move and improving fundamentals could be a turning point. Keep an eye on volume, federal policy headlines, and earnings for the next move.
Leave a Reply